Pityriasis versicolor with cutaneous atrophy

Cataldo Patruno, Francesco Balato, Fabrizio Ayala, Giacomo Riccio

Research output: Contribution to journalArticle

Abstract

Atrophy is a rare occurrence in patients affected by pityriasis versicolor (PV). It is associated with the individual lesions of PV and is reported in patients after long-term application of topical corticosteroids. The present paper describes a case of atrophic PV in female who had used betamethasone valerate 0.1% ointment for 4 months. Avoidance of corticosteroid application and antifungal therapy led to the prompt resolution of PV with improvement of atrophy. The application of topical corticosteroids in areas of impaired cutaneous barrier seems to be the critical factor for the development of atrophy in PV affected patients.

Original languageEnglish
Pages (from-to)94-95
Number of pages2
JournalAnnali Italiani di Dermatologia Allergologica Clinica e Sperimentale
Volume53
Issue number3
Publication statusPublished - Sep 1999

Fingerprint

Tinea Versicolor
Atrophy
Skin
Adrenal Cortex Hormones
Betamethasone Valerate
Ointments

Keywords

  • Corticosteroids
  • Cutaneous atrophy
  • Pityriasis versicolor

ASJC Scopus subject areas

  • Dermatology

Cite this

Pityriasis versicolor with cutaneous atrophy. / Patruno, Cataldo; Balato, Francesco; Ayala, Fabrizio; Riccio, Giacomo.

In: Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale, Vol. 53, No. 3, 09.1999, p. 94-95.

Research output: Contribution to journalArticle

Patruno, Cataldo ; Balato, Francesco ; Ayala, Fabrizio ; Riccio, Giacomo. / Pityriasis versicolor with cutaneous atrophy. In: Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale. 1999 ; Vol. 53, No. 3. pp. 94-95.
@article{a78b7a4146d04e719cca8308b9539ef5,
title = "Pityriasis versicolor with cutaneous atrophy",
abstract = "Atrophy is a rare occurrence in patients affected by pityriasis versicolor (PV). It is associated with the individual lesions of PV and is reported in patients after long-term application of topical corticosteroids. The present paper describes a case of atrophic PV in female who had used betamethasone valerate 0.1{\%} ointment for 4 months. Avoidance of corticosteroid application and antifungal therapy led to the prompt resolution of PV with improvement of atrophy. The application of topical corticosteroids in areas of impaired cutaneous barrier seems to be the critical factor for the development of atrophy in PV affected patients.",
keywords = "Corticosteroids, Cutaneous atrophy, Pityriasis versicolor",
author = "Cataldo Patruno and Francesco Balato and Fabrizio Ayala and Giacomo Riccio",
year = "1999",
month = "9",
language = "English",
volume = "53",
pages = "94--95",
journal = "Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale",
issn = "1592-6826",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "3",

}

TY - JOUR

T1 - Pityriasis versicolor with cutaneous atrophy

AU - Patruno, Cataldo

AU - Balato, Francesco

AU - Ayala, Fabrizio

AU - Riccio, Giacomo

PY - 1999/9

Y1 - 1999/9

N2 - Atrophy is a rare occurrence in patients affected by pityriasis versicolor (PV). It is associated with the individual lesions of PV and is reported in patients after long-term application of topical corticosteroids. The present paper describes a case of atrophic PV in female who had used betamethasone valerate 0.1% ointment for 4 months. Avoidance of corticosteroid application and antifungal therapy led to the prompt resolution of PV with improvement of atrophy. The application of topical corticosteroids in areas of impaired cutaneous barrier seems to be the critical factor for the development of atrophy in PV affected patients.

AB - Atrophy is a rare occurrence in patients affected by pityriasis versicolor (PV). It is associated with the individual lesions of PV and is reported in patients after long-term application of topical corticosteroids. The present paper describes a case of atrophic PV in female who had used betamethasone valerate 0.1% ointment for 4 months. Avoidance of corticosteroid application and antifungal therapy led to the prompt resolution of PV with improvement of atrophy. The application of topical corticosteroids in areas of impaired cutaneous barrier seems to be the critical factor for the development of atrophy in PV affected patients.

KW - Corticosteroids

KW - Cutaneous atrophy

KW - Pityriasis versicolor

UR - http://www.scopus.com/inward/record.url?scp=0033375222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033375222&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033375222

VL - 53

SP - 94

EP - 95

JO - Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

JF - Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

SN - 1592-6826

IS - 3

ER -